ENETS Grants and Awards Winners

Grant & Award Recipients 2025

22nd Annual Conference 2025

• Travel Grant winners
• Best oral presentations
• Best mini oral presentations
• Håkan Ahlman award

Best oral abstract presentations

Basic science

We are pleased to announce the following presenters have been awarded the Best Oral and Mini Oral presentations at the 22nd Annual ENETS Conference. These awards are supported by ENETS and the NET Research Foundation.

• First Place (Tie):

• • Laura MARIËN (Belgium) – “NET-IMPRESS: A novel methylation-based assay to diagnose and monitor NET patients using liquid biopsies”
  • Iacovos MICHAEL (Canada) – “BH3-mimetic drugs elicit cell death of neuroendocrine tumours in preclinical models – An emerging therapeutic strategy for NETs”
• Second Place: James YAO (USA) – “Developing innovative, genetically modified, proliferation-regulated patient-derived models representing human well-differentiated GEP-NETs for drug screening”
• Third Place: Anna BATTISTELLA (Italy) – “Development of new 3D in vitro models for pancreatic neuroendocrine tumours (PanNETs)”
  
  

Clinical science

• First Place: Jaume CAPDEVILA (Spain) – “Efficacy and safety of [177Lu]Lu-edotreotide vs. everolimus in patients with grade 1 or grade 2 gastroenteropancreatic neuroendocrine tumours: COMPETE phase 3 trial”
• Second Place: Eric BAUDIN (France) – “Secondary endpoint results of the first multicentric randomised phase II trial investigating the antitumour efficacy of 177Lutetium-DOTA-Octreotate (OCLU) in advanced progressive neuroendocrine pancreatic tumour: The OCLURANDOM trial”
• Third Place: Julien HADOUX (France) – “Emergence of DNA damage repair clonal haematopoiesis after peptide receptor radionuclide therapy for neuroendocrine tumours”

Best Mini Oral Presentations

Basic Science:

Jelka KUIPER (The Netherlands) – “Familial inactivating glucagon receptor mutation resulting in pancreatic neuroendocrine tumours with metastatic potential, somatic MEN1 mutations, and a heterozygous phenotype”

Clinical Science:

Halfdan SORBYE (Norway) – “Multivariate survival analyses of 544 advanced high-grade digestive neuroendocrine neoplasms (NET G3 and NEC) given first-line chemotherapy (NORDIC NEC 2)”

Winners of the Håkan Ahlman Award 2025

We are proud to announce the winners of this year's ENETS Håkan Ahlman Award, recognising outstanding researchers in neuroendocrine neoplasms. This prestigious award honours the legacy of Håkan Ahlman, a founding member of ENETS and an inspiring researcher.

The recipients of the ENETS Håkan Ahlman Award 2025 are:

Jennifer CHAN (USA)

for her outstanding abstract entitled “Phase 3 Trial of Cabozantinib to Treat Advanced Neuroendocrine Tumors”. (In her absence, Thorvardur Halfdanarson accepted the certificate on her behalf.)

Shani AVNIEL-POLAK (ISR)

for her pioneering research article entitled “Enhancer landscape of lung neuroendocrine tumors reveals regulatory and developmental signatures with potential theranostic implications”.

Travel Grant Winners 2025

We are delighted to announce the recipients of the Travel Grants for the 22nd Annual ENETS Conference. These grants support outstanding individuals in attending the conference, fostering global collaboration and knowledge exchange within the neuroendocrine tumour (NET) community.

Congratulations to the following winners:

• Beatriz Anton Pascual (ESP)
• Simona Avanthay (SUI)
• Zaima Afzal Awan (FRA)
• Anna Battistella (ITA)
• Felix Bolduan (GER)
• Tanvi Brar (USA)
• Olivia Debnath (USA)
• Elisabetta Dell'Unto (ITA)
• Arooj Fatima (PAK)
• Sofia Maria Lider (ROM)
• Laura Mariën (BEL)
• Mohamed Mortagy (GBR)
• Daniel Ruiz Palacios (ESP)
• Elena Trevisani (ITA)
• Anna Vera Verschuur (NED)